Recombinant Human BCAT2 Protein，His

BCAT2, or Branched-Chain Amino Acid Transaminase 2, is a crucial enzyme involved in the metabolism of branched-chain amino acids (BCAAs) such as leucine, isoleucine, and valine, which play significant roles in various physiological processes, including protein synthesis, energy production, and neurotransmitter regulation. Research on BCAT2 has gained prominence due to its potential implications in metabolic disorders, neurodegenerative diseases, and cancer. The enzyme exists in two isoforms, with BCAT2 primarily located in the mitochondria, while its counterpart, BCAT1, is found in the cytoplasm. Understanding the structure and function of BCAT2 is essential for deciphering its role in amino acid homeostasis and energy metabolism. Moreover, BCAT2 has been linked to conditions such as insulin resistance and diabetes, making it a significant target for therapeutic interventions. Recent studies have focused on the biochemical characterization of recombinant BCAT2, which involves expressing the protein in various systems to study its enzymatic activity, substrate specificity, and structural properties. These investigations aid in elucidating the enzyme's mechanism of action and its regulatory pathways, thereby paving the way for advanced research in metabolic therapies. The development of BCAT2 inhibitors or modulators could lead to novel strategies for treating metabolic syndromes, highlighting the importance of this enzyme in health and disease contexts. As the research landscape continues to evolve, the examination of BCAT2 not only enhances our understanding of amino acid metabolism but also contributes to the broader field of metabolic health and disease management, underscoring its importance in clinical and therapeutic research.